Showing results (681-690 of 5,268) with videos related to
Sort By:
Pageof 527
European Journal of Haematology|February 13, 2001
Increased vascularization in myelomaM Laroche, P Brousset, I Ludot, et al.European Journal of Haematology|February 13, 2001
Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimensA Avilés, S Cleto, J Huerta-Guzmán, et al.European Journal of Haematology|November 10, 2000
Circulating endothelial cells in vascular disorders: new insights into an old conceptF Dignat-George, J SampolEuropean Journal of Haematology|November 10, 2000
Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992B Ridell, J Carneskog, H Wedel, et al.European Journal of Haematology|June 26, 2001
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopeniaI Shalit, Y Kletter, D Halperin, et al.European Journal of Haematology|June 26, 2001
Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotypingA Nordgren, F Farnebo, B Johansson, et al.European Journal of Haematology|June 26, 2001
Hydroxyurea and periodicity in myeloproliferative diseaseM Bennett, A J GrunwaldEuropean Journal of Haematology|June 26, 2001
Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myelomaN Gulbrandsen, F Wisløff, E Nord, et al.European Journal of Haematology|May 15, 2001
A single institutional experience with 43 pregnancies in essential thrombocythemiaC A Wright, A TefferiEuropean Journal of Haematology|May 15, 2001
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesT Robak, J Góra-Tybor, E Lech-Marańda, et al.Pageof 527